Pharmacist Medication Insights: Darzalex Faspro for Multiple Myeloma
August 16th 2021Daratumumab and hyaluronidase-fihj (Darzalex Faspro, Janssen) was approved in July in combination with pomalidomide and dexamethasone for the treatment of patients with multiple myeloma following their first or subsequent relapse.
Read More